Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Clinical trial NCT07074496 · RECRUITING
Trial details
- NCT number
- NCT07074496
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-11-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.